Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 16 studies | 38% ± 12% | |
fibroblast | 8 studies | 23% ± 5% | |
endothelial cell | 7 studies | 23% ± 7% | |
pericyte | 7 studies | 21% ± 6% | |
smooth muscle cell | 6 studies | 18% ± 1% | |
basal cell | 6 studies | 24% ± 8% | |
ciliated cell | 5 studies | 29% ± 8% | |
connective tissue cell | 4 studies | 19% ± 3% | |
epithelial cell | 4 studies | 36% ± 19% | |
luminal hormone-sensing cell of mammary gland | 4 studies | 19% ± 2% | |
conventional dendritic cell | 3 studies | 32% ± 10% | |
non-classical monocyte | 3 studies | 20% ± 3% | |
precursor B cell | 3 studies | 20% ± 1% | |
type I pneumocyte | 3 studies | 23% ± 5% | |
dendritic cell | 3 studies | 38% ± 16% | |
goblet cell | 3 studies | 18% ± 3% | |
endothelial cell of vascular tree | 3 studies | 19% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 20% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 637.57 | 180 / 180 | 100% | 22.16 | 430 / 430 |
pancreas | 100% | 456.12 | 328 / 328 | 100% | 20.19 | 178 / 178 |
esophagus | 100% | 740.72 | 1445 / 1445 | 99% | 12.97 | 182 / 183 |
skin | 100% | 1229.20 | 1809 / 1809 | 99% | 27.46 | 468 / 472 |
intestine | 100% | 721.39 | 966 / 966 | 99% | 22.24 | 521 / 527 |
uterus | 100% | 658.12 | 170 / 170 | 99% | 23.28 | 453 / 459 |
prostate | 100% | 773.46 | 245 / 245 | 98% | 23.71 | 494 / 502 |
lung | 100% | 875.58 | 576 / 578 | 99% | 20.14 | 1140 / 1155 |
stomach | 100% | 834.63 | 359 / 359 | 98% | 17.72 | 281 / 286 |
thymus | 100% | 767.83 | 653 / 653 | 98% | 20.25 | 594 / 605 |
brain | 98% | 506.70 | 2592 / 2642 | 100% | 15.77 | 704 / 705 |
bladder | 100% | 723.95 | 21 / 21 | 97% | 21.59 | 491 / 504 |
breast | 100% | 771.11 | 459 / 459 | 97% | 19.75 | 1088 / 1118 |
kidney | 100% | 739.96 | 89 / 89 | 95% | 13.46 | 857 / 901 |
liver | 99% | 488.65 | 223 / 226 | 95% | 11.98 | 384 / 406 |
adrenal gland | 100% | 760.31 | 258 / 258 | 90% | 16.12 | 207 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.56 | 29 / 29 |
spleen | 100% | 778.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.02 | 1 / 1 |
blood vessel | 100% | 765.09 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 760.75 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 654.46 | 801 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 19.77 | 79 / 80 |
heart | 97% | 532.76 | 831 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 511.87 | 882 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_1903059 | Biological process | regulation of protein lipidation |
GO_0000045 | Biological process | autophagosome assembly |
GO_0005829 | Cellular component | cytosol |
GO_1990316 | Cellular component | Atg1/ULK1 kinase complex |
GO_0000407 | Cellular component | phagophore assembly site |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ATG101 |
Protein name | Autophagy-related protein 101 |
Synonyms | C12orf44 PP894 |
Description | FUNCTION: Autophagy factor required for autophagosome formation. Stabilizes ATG13, protecting it from proteasomal degradation. . |
Accessions | F8VVA0 Q9BSB4 H3BMZ4 ENST00000553049.5 ENST00000548915.1 ENST00000336854.9 ENST00000550604.1 F8VQD9 |